Veritable, L.P. Biogen Inc. Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $275 - $318	-1 Reduced 0.02%	4,295 $1.22 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $27,708 - $31,572	108 Added 2.58%	4,296 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $4,039 - $4,907	16 Added 0.38%	4,188 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $23,168 - $31,946	-119 Reduced 2.77%	4,172 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $8,814 - $10,481	47 Added 1.11%	4,291 $875,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $189,700 - $239,013	-979 Reduced 18.74%	4,244 $894,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $223,472 - $287,194	998 Added 23.62%	5,223 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $214,789 - $280,108	-759 Reduced 15.23%	4,225 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $221,186 - $354,162	854 Added 20.68%	4,984 $1.73 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $4,130 - $4,838	17 Added 0.41%	4,130 $1.16 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $141,519 - $213,022	-599 Reduced 12.71%	4,113 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $54,013 - $62,364	-204 Reduced 4.15%	4,712 $1.34 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $77,598 - $102,765	-300 Reduced 5.75%	4,916 $1.32 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $1.45 Million - $1.84 Million	-5,383 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $91,544 - $126,493	416 Added 8.38%	5,383 $1.6 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $869 - $975	4 Added 0.08%	4,967 $1.16 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $314,461 - $346,626	-1,434 Reduced 22.42%	4,963 $1.16 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $37,707 - $58,979	-174 Reduced 2.65%	6,397 $1.51 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $147,605 - $186,957	-530 Reduced 7.46%	6,571 $1.98 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $73,083 - $95,573	249 Added 3.63%	7,101 $2.51 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $13,648 - $16,266	53 Added 0.78%	6,852 $1.99 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $131,885 - $186,530	507 Added 8.06%	6,799 $1.86 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $329,174 - $368,700	-1,070 Reduced 14.53%	6,292 $2 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $2.07 Million - $2.43 Million	7,362	7,362 $2.31 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account